SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM HEPATITIS B SURFACE ANTIGEN II (HBSII); TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
|
Back to Search Results |
|
Model Number N/A |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/07/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
A customer from outside the united states reported observation of nonreactive (negative) atellica im hepatitis b surface antigen ii (hbsii) results for one patient which were discordant relative to patient medical history and alternate-method testing.When the patient's sample was re-tested using an alternate method at an alternate site, a positive result was obtained which was considered consistent with the patient¿s medical history.No issues were noted with assay quality control (qc).There are no allegations of patient harm, changes in treatment, or delays of diagnosis in association with the observed result discordance.Siemens is investigating.
|
|
Event Description
|
The customer reports observation of nonreactive atellica im hepatitis b surface antigen ii (hbsii) results for one patient which were discordant relative to patient medical history and alternate-method testing.A nonreactive hbsii result was obtained for an 85-year-old male patient.This result was reported to the physician and questioned.The same sample was tested using an alternate method at an external lab, and a positive result was returned, which was considered consistent with the patient¿s medical history.The customer states that re-testing of the sample following dilution (2-fold and 4-fold) also produced nonreactive hbsii results.There are no reports that treatment was altered or prescribed or of adverse health consequences due to the discordant nonreactive atellica im hbsagii results.
|
|
Manufacturer Narrative
|
Mdr 2432235-2023-00183 was initially reported on 2023-06-23.A customer from outside the united states reported observation of nonreactive atellica im hepatitis b surface antigen ii (hbsii) results for one patient which were discordant relative to patient medical history and alternate-method testing.Siemens reviewed the available information and data, including customer quality control (qc) results, which were within assigned ranges.No similar complaints were identified in a search of the complaint database.Additional information has been requested from the customer on multiple occasions, but none has been provided.Further evaluation is not possible without additional information.On the basis of the available information, no product problem was identified.The customer is operational.Note: in section h6, the codes for investigation findings and investigation conclusion have been updated.
|
|
Search Alerts/Recalls
|
|
|